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ABSTRACT
Skin lesions, apart from diarrhoeas, fever of unknown origin, and respiratory tract infections belong to the 
most frequent medical problems in travellers returned from tropical and subtropical destinations, account­
ing more than 10% of reported cases. Most dermatoses have their clinical onset during travel, although 
some of them can occur after return. Travel­related dermatological problems can have a wide spectrum of 
clinical picture, from macular, popular or nodular rash, linear and migratory lesions, to plaques, vesicles, 
bullae, erosions or ulcers. Skin conditions in returning travellers may be of infectious and non­infectious 
aetiologies. Infectious lesions may be originally tropical (e.g. dengue, chikungunya, schistosomiasis, leish­
maniasis, myiasis, tungiasis, loiasis), although the majority are cosmopolitan (arthropod bites, sunburns, 
allergic rashes). The evaluation of skin lesions depends on many factors, including immune status of pa­
tients, use of medicines, exposure on health hazards (fauna, flora, risky behaviours), as well as the time, 
duration and location of travel. As the number of travellers to tropical and subtropical destinations has 
been continuously rising, the number of skin illnesses has also been increasing. This means that specia­
lists in travel medicine need to extend their knowledge of epidemiology, clinical features and diagnosis of 
travel­related health problems including skin lesions in returning travellers. 
(Int Marit Health 2015; 66, 3: 173–180)
Key words: skin lesions, returning travellers, tropics

INTRODUCTION
Skin lesions, apart from diarrhoeas, fever of unknown 
origin, and respiratory tract infections belong to the most 
frequent medical problems in travellers returned from trop-
ical and subtropical destinations [1]. According to the data 
obtained from travel medicine clinics [2–4], skin illnesses 
are the third most common reason for consultation and 
treatment among returning travellers, accounting for more 
than 10% of cases [3, 5]. Potentially, 10% of travel-related 
skin conditions may be serious enough to lead to hospi-
talisation [6]. Most dermatoses have their clinical onset 
during travel, with the remainder tending to occur a median 
of 1 week after return [7]. Travel-related dermatological 
problems can have a wide spectrum of clinical symptoms. 
The most common are macular, popular, nodular, linear, 
erosion and ulcerative lesions. Macular lesions may oc-
cur due to drug reactions and superficial mycoses (tinea 
versicolor, tinea corporis). Papular lesions can appear as 
a result of insect bites or hypersensitivity reactions. Nodular 
lesions are connected with bacterial infections (pyodermas) 
or can rise in the process of parasitic infection, e.g. myiasis, 
tungiasis or filariasis. Linear lesions may appear in para-
sitic infections (cutaneous larva migrans, larva currens) 
or noninfectious conditions (e.g. phytophotodermatitis). 
Erosive and ulcerative lesions originally occur as pyoder-
mas (caused by Staphylococcus aureus, Streptococcus 
pyogenes) or parasitic infection (cutaneous leishmaniasis), 
and secondarily as a result of scratching itchy lesions (e.g. 
arthropod bites) or superficial injuries of the skin. Derma-
tological manifestations in returned travellers fall into two 
categories: lesions associated with fever (rash in the process 
of viral infections, e.g. dengue, chikungunya, secondary 
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bacterial infections, rickettsial infections) and those not 
associated with fever (most dermatoses). The diagnosis 
of skin illnesses is based on the type of lesions (macular, 
popular, nodular, linear, ulcerative), location (exposed vs. 
unexposed), patient’s history (contact with insects, animals, 
humans, cosmetics, drugs, etc.), and associated symptoms 
(fever, pain, pruritus). It is important to determine if the skin 
problems are travel-related [1]. Skin conditions in returning 
travellers can be both of infectious and non-infectious ae-
tiologies. Infectious skin lesions may be tropical in origin 
(25%), although the majority are cosmopolitan [4]. Some of 
them can be the result of insects’ bites, sunburn, bacterial 
infections or allergic rash. Travel rashes may be acquired 
from exposure to sun, heat, medicines, insects, marine life 
and/or a wide range of infectious agents: viruses, bacteria, 
fungi and parasites [8]. The predominant skin symptom is 
an important clue — itching suggests an allergic aetiology, 
tenderness at the infection site suggests infection [9]. The 
evaluation of skin lesions in travellers depends on many 
factors, including immune status of patients, use of med-
icines (taken during travel), time and duration of travel, 
destination and exposure to health hazards (fauna and flora, 
risky behaviors, e.g. extreme sports). The risk for dermato-
logical infections increases among patients with AIDS, organ 
transplant recipients, patients undergoing chemotherapy 
or taking immunomodulatory medications, elderly people, 
diabetics, pregnant women [10].
EPIDEMIOLOGY
International tourist arrivals have increased from 25 
million in 1950 to 278 million in 1980, 527 million in 
1995, and 1133 million in 2014. According to the United 
Nations World Tourism Organisation (UNWTO), the number 
of international tourist arrivals is expected to increase by 
3.3% a year and to reach 1.8 billion by 2030 [11]. Along 
with the increasing number of travellers, a significant growth 
in travel-related illnesses is observed. Dermatoses are 
a leading cause of health problems in travellers including 
infectious illnesses of exotic or cosmopolitan origin as well 
as environmental skin manifestations. Research results 
illustrate that the leading dermatological problems observed 
during travel are infections and environmental skin illnesses 
(arthropod-induced pruritic dermatitis, sunburns, marine-as-
sociated dermatitis, and superficial injuries) [12]. 
According to the data obtained from the GeoSentinel 
Surveillance Network clinics, 4,594 of all returned travellers 
(mainly from Southeast Asia, sub-Saharan Africa and South 
America) consulted by specialists in tropical and travel 
medicine in the period from 1997 to 2006 were diagnosed 
with skin illnesses (18% of all patients who sought medical 
care). The most common travel-related dermatoses were 
arthropod bites including secondary infections, pyoder-
mas, allergic rashes, and cutaneous larva migrans. Arthro-
pod-related skin illnesses (insects bites, dengue, cutaneous 
leishmaniasis) accounted for 31% of all dermatological 
diagnoses; 15% dermatoses were of unknown aetiology 
(rash, urticarial, pruritus) [8]. The GeoSentinel Network 
data from over 42 thousand patients worldwide (from 53 
travel/tropical clinics located in 24 countries), who were 
evaluated after foreign travel, revealed that a skin disorder 
diagnosis was made in 19.5% of patients presenting to 
physicians, which was the third most common diagnosis 
after gastrointestinal (34%) and febrile illnesses (23%) [13]. 
Studies from Maldives and Fiji [14, 15] revealed that der-
matoses were the most frequent illnesses in tourists, with 
sunburns, superficial injuries (including those due to contact 
with marine creatures), and skin infections reported most 
often. In the study of Freedman et al. [2], involving more 
than 17 thousand returning travellers, skin diseases were 
the third most common cause of health problems after 
febrile illnesses and acute diarrhoeas. The most common 
causes of dermatological problems were arthropod bites 
(with or without secondary infection), cutaneous larva mi-
grans, allergic reactions, and pyodermas. Herbinger et al. [3] 
studied the data of over 34 thousand travellers returning 
from tropical and non-tropical countries to Germany in the 
period 1999–2009. The tourists’ main destinations were 
Asia (40%), Africa (27%), and Latin America (21%). According 
to the research results 12.2% of all health problems were 
skin illnesses. The leading causes of skin manifestations 
were arthropodal (23%), bacterial (22%), helminthic (11%), 
protozoan (6%), viral (6%), allergic (5%), and fungal (4%). 
The most frequently diagnosed skin illnesses were insect 
bites (17%), cutaneous larva migrans (8%), cutaneous leish-
maniasis (2.4%), dengue fever (1.5%), rickettsioses (1.3%), 
myiasis (0.8%), filarioses (0.7%), schistosomiasis (0.6%), 
and tungiasis (0.6%). In the study of Solomon et al. [16], 
realised during 10 years (1998–2008) in Israel, 2,834 
post-travel patients were examined, of whom 19% suffered 
from skin disorders. Among them 53% suffered from infec-
tious (tropical: cutaneous larva migrans, cutaneous leish-
maniasis, myiasis; non-tropical: pyodermas, cellulitis) and 
47% from noninfectious lesions. The most common group 
in this study were tropical diseases (63.5%), and among 
them leishmaniasis was a leading illness.
Skin problems develop as a result of a variety of factors: 
exposure to new medications, extremes of temperature and 
humidity, exposure to plant or animal toxins. Skin conditions 
may be associated with the length of stay and environmental 
risks. Travellers who stay in urban centres in high standard 
accommodation for a brief period are much less likely to 
acquire a local skin disorders than those living with locals 
in rural areas for a long time [8]. Owing to the complexity of 
the diagnostic and therapeutic process, it is important to be 
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Table 1. Skin lesions associated with travel-related infections. Source: [4, 19]
Skin lesions Infection
Maculopapular rash Dengue, chikungunya, schistosomiasis, Rickettsia spp., superficial fungal infections
Papular rash Scabies, blastomycosis, histoplasmosis
Nodular rash Myiasis, tungiasis
Vesicular/bullous rash Herpes simplex, Herpes zoster
Linear lesions Cutaneous larva migrans, strongyloidiasis (larva currens)
Migratory skin lesions Cutaneous larva migrans, strongyloidiasis (larva currens), loiasis
Erosions/ulcers Leishmaniasis, pyodermas
Lymphangitis Sporotrichosis, leishmaniasis
Jaundice Malaria, leptospirosis
Haemorrhagic lesions Dengue, leptospirosis, meningococcal infection, Rickettsia spp.
Table 2. Causes of localized dermatoses in travellers according to the primary skin lesions. Source: [20]
Skin lesions Causes of dermatoses
Papules and nodules Noninfectious causes (arthropod bites)
Bacterial infection (pyodermas, mycobacterial infection)
Parasitic infection (leishmaniasis, tungiasis, myiasis, schistosomiasis)
Fungal infection (mycetoma, sporotrichosis)
Viral infection (orf)
Erythematous plaque Bacterial infection (pyodermas, cellulitis)
Parasitic infection (schistosomiasis, leishmaniasis)
Fungal infection (dermatophytosis)
Vesicles and bullae Noninfectious causes (sunburn, contact dermatitis, irritant dermatitis, arthropod bites)
Bacterial infection (impetigo)
Parasitic infection (cutaneous larva migrans)
Viral infection (Herpes simplex, Herpes zoster)
Ulcers Noninfectious causes (spider bite)
Bacterial infection (pyodermas, syphilis, tularaemia, anthrax)
Parasitic infection (leishmaniasis, sporotrichosis)
Fungal infection (mycetoma, chromomycosis)
Viral infection (Herpes zoster)
aware of the epidemiology and clinical features of dermato-
ses occurring among patients returning from various travel 
destinations, especially from the tropics and subtropics.
CLINICAL SYMPTOMS OF  
TRAVEL-RELATED DERMATOSES
Returned travellers often present to medical facilities 
with unique clinical manifestations. Dermatological mani-
festations of travel-related health problems are particular-
ly problematic because of a broad differential diagnosis 
and physicians’ unfamiliarity with rare diseases [17]. The 
spectrum of travel-related dermatoses seems to be closely 
related to the geographic area visited and the onset of 
signs and symptoms is related to the date of return. Sun-
burns, arthropod-related reactions and superficial injuries 
most often occur during the patient’s stay abroad and are 
most common in hot-climate seaside destinations. Skin 
infections, particularly pyodermas, are cosmopolitan and 
are a common cause of dermatoses during travellers’ stay 
abroad as well as after their return [18]. Skin manifesta-
tions in travellers can be divided into two main categories: 
noninfectious (including arthropod bites, allergic reactions, 
sunburns, endogenous dermatological conditions) and in-
fectious. Dermatoses can be further divided into infectious 
tropical (e.g. cutaneous, larva migrans, cutaneous leishman-
iasis, schistosomiasis, myiasis, tungiasis, rickettsial infec-
tions, dengue, chikungunya, loiasis) and infectious non-trop-
ical or cosmopolitan (pyodermas, scabies, superficial fun-
gal infections, Herpes simplex, Herpes zoster) (Table 1) 
[4, 19]. Causes of localised dermatoses according to the 
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primary skin lesions are presented in Table 2 [20]. Some 
skin diseases, infectious and noninfectious, seen typically 
in a non-travel context, may be exacerbated by travel to 
the tropics. Examples include eczema, purulent and fungal 
infections which thrive in hot, humid environments [21].
Clinical symptoms of the most common dermatoses 
observed in travellers visiting tropical and subtropical des-
tinations are discussed below.
Arthropod bites. Bites or stings from arthropods result 
in local skin lesions due to allergic reaction or toxin release. 
Arthropods include a wide group of fauna: insects, arach-
nids, crustaceans, mites, ticks, centipedes, and others [4]. 
Arthropod bites are extremely common and account for 
10% of dermatoses in travellers returned from the tropics 
and 15–18.7% of dermatoses in travellers worldwide [8, 
22]. Allergic reactions may occur in minutes to hours after 
a bite of a sting. A secondary bacterial infection after bite, 
e.g. because of scratching, may appear days later. Common 
presentations include pruritic papules (after mosquito or 
sand fly bite), eschar of ulcer (ticks, spider) [4].
Bacterial skin infections. The clinical spectrum ranges 
from impetigo (Staphylococcus aureus and Streptococcus 
spp. are the main reported etiological factors), folliculitis, 
ecthyma, erysipelas, abscess, to necrotising cellulitis [12]. 
A secondary infection after insect bites is also a common 
cause of bacterial skin infection [2]. According to Lederman 
et al. [8] bacterial skin infections (including pyodermas 
and infected insect bites) are the most common cause 
of dermatoses reported in the GeoSentinel Surveillance 
Network medical centres consulting thousands of travellers 
returning from the tropics, especially from African (Madagas-
car, Kenya, South Africa) and Asian continent (Philippines, 
Thailand, Sri Lanka).
Dengue/chikungunya. After malaria, dengue is the 
second most common cause of systemic febrile illness in 
returning travellers worldwide, especially in Central America 
and sub-Saharan Africa [2]. Clinically, in 30–50% of dengue 
cases, except for fever, myalgia, headache, retro-orbital 
pain, maculopapular rash is seen. Diffuse erythema, pete-
chiae, or haemorrhagic lesions can also be observed [23]. 
Most patients present with classic dengue fever and have 
benign febrile illness, but dengue haemorrhagic fever and 
dengue shock syndrome can also occur among returned 
travellers [20]. Similarly to dengue, in chikungunya (diag-
nosed from Africa and Asia, and recently in southern Europe 
and the Americas) in 50% of the cases maculopapular rash 
is observed, located mainly in trunk or extremities [24]. Ar-
thralgia, arthritis, or tenosynovitis can be also observed and 
may last several months to years after the onset of infection 
[25]. Chikungunya and dengue skin manifestations are 
difficult to differentiate. Rash is a common feature shared 
by both diseases, it looks similar and affects roughly the 
same number of patients in both cases. However, the dis-
eases may be distinguished by other clinical variables, e.g. 
lymphopoenia is significantly more frequent in chikungunya, 
whereas leukopenia, neutropenia, and thrombocytopenia 
are significantly more common in dengue [20, 26]; shock 
and gastrointestinal haemorrhages are complications as-
sociated with dengue fever, whereas long-lasting arthralgia 
is a complication specifically associated with chikungunya 
[27, 28].
Schistosomiasis. The majority of travel-associated in-
fections occur in travellers visiting sub-Saharan Africa (an 
estimated 85% of the world’s cases of schistosomiasis 
are in African continent). Schistosoma haematobium and 
S. mansoni are distributed throughout Africa; only S. haema­
tobium is found in the Middle East; S. japonicum is found 
in Indonesia, the Philippines and parts of China. Two other 
species, rarely reported in humans, are S. mekongi found 
in Cambodia and Laos, and S. intercalatum found in parts 
of Central and Western Africa [29]. Schistosoma may infect 
the urinary tract (S. haematobium) or the intestines (other 
species). Invasion of the skin by the cercariae present in the 
fresh water gives rise to a pruritic papular rash that appears 
a few hours after exposure and usually lasts less than 48 h 
(cercarial dermatitis, swimmer’s itch). Another phase of the 
infection is an acute schistosomiasis (Katayama syndrome), 
with the most common symptoms such as fever (in 70% of 
cases), skin lesions, cough, malaise, headache, hepato-
splenomegaly and marked eosinophilia. Fever might be the 
first symptom of the disease and can be accompanied by 
urticarial rash and angioedema. The urticarial rash appears 
in 30–50% of patients and may last for about 8 days. It is 
a diffuse migratory rash, which often prompts patients to 
seek immediate medical care, at which time the patient 
may be diagnosed as having “allergic reactions” and treat-
ed with antihistamines or glucocorticoids, without further 
evaluation [30].
Rickettsial infections. Rickettsioses are zoonotic bacteri-
al infections transmitted to humans by arthropods. Regard-
less of the causative agent, most patients usually present 
with a benign febrile illness accompanied by headache, 
myalgia and skin lesions (rash, cutaneous eschar) [20]. 
Severe complications such as multiple organ failure and 
fatalities are occasionally seen [31]. The leading cause of 
rickettsiosis reported in travellers is African tick-bite fever 
(ATBF), transmitted by cattle Amblyomma ticks and caused 
by Rickettsia africae. ATBF is endemic in rural sub-Saharan 
Africa and frequently occurs in clusters among travellers 
during hunting, safaris, adventure races [32]. Rash can 
occur in > 40% of patients diagnosed with this infection 
[33]. The characteristic skin lesion is a black eschar, which 
is found at the site of inoculation of R. africae. Patients may 
also develop a more generalised maculopapular or vesicular 
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rash [19]. Other rickettsial infections can be seen endemic 
worldwide (e.g. Orientia tsutsugamuschi in South and South-
eastern Asia and the Western Pacific, Rickettsia conorii in 
Mediterranean Europe, Africa, and Asia, Rickettsia rickettsia 
in the Americas) and in their clinical picture, dermatological 
symptoms vary from focal lesions (eschar) to disseminated 
rashes, usually macular or petechial [34, 35].  
Cutaneous leishmaniasis (CL). 90% of the world cases of 
cutaneous leishmanisis (1.5 million of new cases every year) 
are observed in Afghanistan, Algeria, Brazil, Peru, Saudi 
Arabia, Iran, Iraq and Syria [36]. Endemic foci of CL exist in 
southern France and Greece, periodic outbreaks have oc-
curred in Spain [37–39]. CL is more common in rural areas, 
in settings ranging from rainforests to arid regions. However 
it is increasingly reported in urban and suburban areas, 
where a number of opportunistic hosts, such as dogs and 
donkeys, have become the reservoir of infection [36]. The 
types of skin lesions vary and may progress from papules, 
plaques, nodules to ulceration. The classic manifestation 
of cutaneous leishmaniasis is a predominantly painless 
ulcer with raised, indurated margins, along with granulation 
tissue or eschar [19]. Because the lesions are located at 
the site of the sand fly bite (vector of leishmaniasis), they 
are typically found on areas of exposed skin such as the 
extremities or face. The skin lesions can develop within 
weeks to months of exposure or even years later, often in the 
setting of trauma or immunosuppression. Left untreated, 
they may last months to years [40]. The average number of 
lesions varies from 1 to 3 and rarely exceeds 10 per patient. 
The cutaneous form of leishmaniasis is often benign and 
self-limiting [41]. In travellers returning from South America, 
where except for CL, the mucocutaneous form of disease 
also occurs; the clinical spectrum of leishmaniasis is larger, 
ranging from ulcerative skin lesions to destructive mucosal 
inflammation [42]. 
Cutaneous larva migrans (CLM). Skin infection caused 
by hookworms, is one of the most common in travellers 
returning from the tropics [43], especially from sub-Saharan 
Africa, Asia, South America and the Caribbean (the most 
common countries include Brazil, Jamaica, Malaysia and 
Thailand) [44, 45]. According to selective studies the rates 
of cutaneous larva migrans among travellers range from 
5% up to 25% [2, 8, 22, 46]. The incidence of CLM follows 
a seasonal pattern, with more infections occurring during 
the rainy seasons [47]. After direct contact with surface con-
taminated the faeces, e.g. soil, the hookworm larvae pene-
trate the skin and migrate in the superficial tissue (mainly 
in lower extremities as a result of walking barefoot on the 
beach or on sandy soil). The incubation period of CLM is 
usually a few days and rarely goes beyond 1 month [12]. The 
clinical picture manifests as an erythematous, linear or ser-
piginous track (approx. 3 mm wide and 15–20 mm in length; 
it may extend a few millimetres to a few centimetres daily), 
and can be associated with a pruritic popular (mostly) or 
vesiculobullous rash (up to 15% cases) [48, 49]. The mean 
number of lesions per person varies from 1 to 3 [49, 50]. 
Pruritus localised at the site of the eruption is reported in 
98–100% of patients [50]. Most cases present with symp-
toms within weeks of exposure, rare cases are present 
months later [51]. CLM is self-limited (hookworms die in the 
skin as they are unable to penetrate further), but migration 
can persist for weeks to months (usually 2–8 weeks) with 
associated pruritus and discomfort. When left untreated, 
the lesions of CLM can become infected with bacterial 
pathogens (mostly as a result of scratching the skin) leading 
to secondary pyodermas [52].
Strongyloidiasis (larva currens). Cosmopolitan skin in-
fection caused by the nematode Strongyloides stercoralis. 
The prevalence of helminthiasis is the highest in tropical and 
subtropical regions. Humans become infected by contact 
with soil containing infectious larvae of S. stercoralis. The 
larvae penetrate the intact skin. Gastrointestinal (abdominal 
pain, diarrhoea), pulmonary (Löffler’s syndrome), and skin 
symptoms appear as a result of parasite’s migration through 
the host’s body [53]. There are two types of dermatological 
manifestations in strongyloidiasis. One is a visible linear or 
serpiginous creeping lesion (larva currens) with associated 
pruritus, mostly around the anus and anywhere on the trunk 
[19]. Unlike cutaneous larva migrans, larva currens migrate 
much faster than hookworms at a rate of 2–10 cm per hour 
as opposed to centimetres per day. The cutaneous lesions 
tend to persist for only hours to days and then completely 
disappear, but the lesions may recur frequently [52]. The 
second form of skin lesions in strongyloidiasis is an urticar-
ial rash in an individual who has already been sensitised. 
This urticarial rash occurs predominantly in the buttocks 
and around the waist, lasts 1–2 days and may recur as 
a first form frequently at regular intervals [53]. An important 
feature of S. stercoralis is an ability to complete its lifecy-
cle within the human body, leading to continuing cycles of 
autoinfection [54]. It’s important to notice that chronic or 
persistent infection may remain asymptomatic over decades 
and culminate in severe and potentially life-threatening 
S. stercoralis hyperinfection syndrome once an individual 
sustains immunosuppression (e.g. chemotherapy, organ 
transplantation) [55, 56].  
Myiasis/tungiasis. Infestations related to the presence 
of larvae or maggots of flies in human tissue. Dermatoses 
occur mainly in tropical and subtropical regions (myiasis can 
also occur in temperate climate), particularly in sub-Saharan 
Africa, South and Central America, and the Caribbean. Myia-
sis most commonly presents as an erythematous furuncle 
at the site of invasion with botfly (Dermatobia hominis) 
and tumbu fly (Cordylobia anthropophaga) as the most 
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common causative agents. The incubation period varies 
from 7 days to 3 weeks [22]. C. anthropophaga lesions 
are more commonly multiple, whereas D. hominis lesions 
usually number from 1 to 3 [57]. Clinically, pruritus and the 
moving sensation at the lesion site with lancinating pain 
are seen [58]. If not associated with a pre-existing wound, 
the typical lesion of myiasis is nodular. Also, the disease 
may present with furuncular lesions, and thus it can be 
mistaken for a staphylococcal furuncle. The lesion usually 
has a small opening to allow for respiration, and patients 
sometimes report a sensation of movement within the skin. 
Risk factors for acquiring myiasis include open wounds and 
peripheral vascular disease [59]. 
Tungiasis is a result of penetration of the skin (more 
superficial than in myiasis) by sand or jigger flea (Tunga 
penetrans), usually between the toes or under toenails. The 
infection is acquired by walking barefoot in regions where 
T. penetrans is found (usually beaches or sandy soil). Animal 
reservoirs include dogs, cats, pigs, and rats [60]. The tiny 
female flea (approx. 1 mm), burrows into the outer layer of 
the skin, generating the characteristic white papule or nod-
ule with a central black point [61]. The burrowing process 
is asymptomatic, but the gravid female increases in size to 
up to 1 cm in about 2 weeks, creating a pruritic or painful 
nodular lesion from which eggs and faeces are excreted 
[62]. The flea usually dies and is sloughed with the host’s 
skin over several weeks [63].
Loiasis. Filarial parasitic infection present in Western 
and Central Africa transmitted by bloodsucking flies. Most 
infections are asymptomatic. The classical loiasis caused 
by filaria (adult worm, 3–7 cm × 0.4 mm), migrating under 
the conjunctiva of the eye is rarely observed, as the visible 
passage of the worm only lasts 10–15 min [56]. More often, 
symptomatic loaiasis manifest as localised angioedema in 
response to subcutaneous migration of parasites [64]. The 
most frequent symptoms are recurrent subcutaneous soft 
tissue swellings (Calabar swellings) and chronic pruritus. 
Calabar swellings are painless, non-pitting angioedemas, 
most commonly observed on the hands, wrists and fore-
arms, lasting a few hours to several days [56].
SUMMARY
Skin lesions are the third most common health problems 
in returning travellers, accounting for more than 10% of re-
ported cases. Dermatoses have a wide spectrum of clinical 
symptoms, from macular, popular, nodular, linear, to erosion 
and ulcerative lesions. Tropical illnesses make up about one 
quarter of dermatological infections or infestations (mainly 
cutaneous larva migrans, myiasis, tungiasis, cutaneous 
leishmaniasis) and the remainder are cosmopolitan (arthro-
pod bites, bacterial skin infections, allergic reactions, animal 
bites, superficial fungal infections). Differential diagnoses of 
skin illnesses depend on the patient’s travel history (place 
of stay and duration of journey, local endemicity, certain 
diseases) and the clinical picture of dermatoses. Some 
dermatological problems can be self-limited, because of that 
some travellers do not seek medical assistance during and 
after journey. It must be remembered that dermatoses tend 
to develop much faster and more frequently in hot climate 
zones which is associated with increased secretion of sweat 
and sebum. In tropical regions travellers are exposed to 
a much larger number of insects (vectors of arthropod-borne 
diseases) than in temperate climate areas, they are also 
exposed to contaminated soil and water which translates 
into increased prevalence of health problems presenting 
with dermatological symptoms. Because the number of 
travellers to tropical and subtropical destinations has been 
continuously rising, the number of skin illnesses has also 
been increasing. This means that specialists in travel medi-
cine need to extend their knowledge of epidemiology, clinical 
features and diagnosis of travel-related health problems 
including skin lesions in returning travellers.
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